Cargando…
Assessment of Impact of Human Leukocyte Antigen-Type and Cytokine-Type Responses on Outcomes after Targeted Therapy Currently Used to Treat Chronic Lymphocytic Leukemia
Tumor growth and metastasis are reliant on intricate interactions between the host immune system and various counter-regulatory immune escape mechanisms employed by the tumor. Tumors can resist immune surveillance by modifying the expression of human leukocyte antigen (HLA) molecules, which results...
Autores principales: | Andreescu, Mihaela, Berbec, Nicoleta, Tanase, Alina Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094967/ https://www.ncbi.nlm.nih.gov/pubmed/37048814 http://dx.doi.org/10.3390/jcm12072731 |
Ejemplares similares
-
CLL-370: The Prolonged Positivity of SARS-CoV-2 RNA in Chronic Lymphocytic Leukemia Patients
por: Popov, Viola, et al.
Publicado: (2020) -
Etiopathogenesis and prognostic implications of autoimmune hemolytic anemia association with chronic lymphocytic leukemia B
por: Oprea, MM, et al.
Publicado: (2012) -
Real-World Clinical Outcomes and Adverse Events in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib: A Single-Center Retrospective Study
por: Moldovianu, Ana-Maria, et al.
Publicado: (2023) -
Advances in treating chronic lymphocytic leukemia
por: Tausch, Eugen, et al.
Publicado: (2014) -
The type of lymphocyte infiltration near urothelial carcinoma is diagnostic for chronic lymphocytic leukemia
por: Baseskiogulu, Barbaros, et al.
Publicado: (2013)